Eversept Partners as of Sept. 30, 2019
Portfolio Holdings for Eversept Partners
Eversept Partners holds 59 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| GlaxoSmithKline | 13.2 | $42M | 983k | 43.07 | |
| Ensign (ENSG) | 8.7 | $28M | 587k | 47.47 | |
| Danaher Corporation (DHR) | 8.1 | $26M | 179k | 144.59 | |
| Zogenix | 8.1 | $26M | 644k | 40.04 | |
| Ascendis Pharma A S (ASND) | 7.1 | $23M | 236k | 96.32 | |
| Amarin Corporation (AMRN) | 6.3 | $20M | 1.3M | 15.16 | |
| Sanofi-Aventis SA (SNY) | 3.5 | $11M | 240k | 46.33 | |
| Radius Health | 2.8 | $8.9M | 345k | 25.75 | |
| Envista Hldgs Corp (NVST) | 2.8 | $8.9M | 318k | 27.88 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.7 | $8.6M | 51k | 169.42 | |
| Illumina (ILMN) | 2.5 | $8.1M | 27k | 304.22 | |
| Alnylam Pharmaceuticals (ALNY) | 2.3 | $7.4M | 92k | 80.42 | |
| Audentes Therapeutics | 2.2 | $7.1M | 254k | 28.09 | |
| Dex (DXCM) | 2.1 | $6.6M | 45k | 149.25 | |
| R1 Rcm | 2.0 | $6.5M | 726k | 8.93 | |
| Abiomed | 1.7 | $5.3M | 30k | 177.90 | |
| Omega Healthcare Investors (OHI) | 1.4 | $4.5M | 107k | 41.79 | |
| Tg Therapeutics (TGTX) | 1.4 | $4.3M | 774k | 5.61 | |
| Oxford Immunotec Global | 1.3 | $4.3M | 256k | 16.63 | |
| Teligent | 1.3 | $4.2M | 4.4M | 0.95 | |
| Argenx Se (ARGX) | 1.3 | $4.1M | 36k | 113.96 | |
| LTC Properties (LTC) | 1.1 | $3.6M | 69k | 51.22 | |
| Sabra Health Care REIT (SBRA) | 1.1 | $3.5M | 154k | 22.96 | |
| Model N (MODN) | 1.1 | $3.4M | 121k | 27.76 | |
| Caretrust Reit (CTRE) | 1.0 | $3.3M | 138k | 23.72 | |
| BioDelivery Sciences International | 0.9 | $3.0M | 708k | 4.21 | |
| ArQule | 0.9 | $3.0M | 412k | 7.17 | |
| Heska Corporation | 0.9 | $2.9M | 41k | 70.87 | |
| eHealth (EHTH) | 0.9 | $2.8M | 43k | 66.79 | |
| Community Health Systems (CYH) | 0.7 | $2.2M | 607k | 3.60 | |
| Fate Therapeutics (FATE) | 0.7 | $2.2M | 141k | 15.53 | |
| Cytokinetics (CYTK) | 0.7 | $2.1M | 182k | 11.38 | |
| Tricida | 0.6 | $2.0M | 66k | 30.87 | |
| Macrogenics (MGNX) | 0.6 | $2.0M | 155k | 12.76 | |
| Xenon Pharmaceuticals (XENE) | 0.6 | $1.9M | 216k | 9.01 | |
| Apellis Pharmaceuticals (APLS) | 0.6 | $1.9M | 80k | 24.09 | |
| BioCryst Pharmaceuticals (BCRX) | 0.6 | $1.9M | 655k | 2.86 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.6 | $1.8M | 160k | 11.48 | |
| Scpharmaceuticals (SCPH) | 0.4 | $1.3M | 222k | 5.87 | |
| Amarin Corp Plc option | 0.3 | $1.1M | 1.6k | 680.32 | |
| Agile Therapeutics | 0.3 | $1.1M | 910k | 1.19 | |
| Invacare Corporation | 0.3 | $970k | 129k | 7.50 | |
| Affimed Therapeutics B V | 0.3 | $947k | 322k | 2.94 | |
| Otonomy | 0.3 | $900k | 376k | 2.39 | |
| Codexis (CDXS) | 0.3 | $864k | 63k | 13.71 | |
| Savara (SVRA) | 0.3 | $839k | 317k | 2.65 | |
| Deciphera Pharmaceuticals (DCPH) | 0.2 | $747k | 22k | 33.95 | |
| Optinose (OPTN) | 0.2 | $736k | 105k | 7.00 | |
| Eiger Biopharmaceuticals | 0.2 | $715k | 70k | 10.26 | |
| Dicerna Pharmaceuticals | 0.2 | $590k | 41k | 14.36 | |
| Newlink Genetics Corporation | 0.1 | $434k | 273k | 1.59 | |
| Pfenex | 0.1 | $405k | 48k | 8.44 | |
| Albireo Pharma | 0.1 | $361k | 18k | 20.02 | |
| Akorn | 0.1 | $153k | 40k | 3.80 | |
| Healthequity (HQY) | 0.0 | $37k | 640.00 | 57.81 | |
| Aimmune Therapeutics Inc call | 0.0 | $21k | 91.00 | 230.77 | |
| Celgene Corp right 12/31/2011 | 0.0 | $3.0k | 6.0k | 0.50 | |
| Aimmune Therapeutics Inc put | 0.0 | $15k | 100.00 | 150.00 | |
| Cel-sci Corp | 0.0 | $10k | 428.00 | 23.36 |
